echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > Since December 20, the online price of a large number of drugs in the area has been reduced, with a maximum reduction of 3,162 yuan

    Since December 20, the online price of a large number of drugs in the area has been reduced, with a maximum reduction of 3,162 yuan

    • Last Update: 2022-12-30
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    With the continuous advancement of the centralized procurement of drugs organized by the state, the reshuffle of the pharmaceutical market has accelerated, and the competition between pharmaceutical companies has become more and more intense, and the price adjustment and withdrawal of drugs have become the norm
    .

     
    Recently, the website information of the Hubei Provincial Medical Security Bureau shows that the bureau has reviewed and publicized some drugs that voluntarily applied for a reduction in the online price in November 2022, and a total of 22 online drugs have been adjusted to the online price, involving 21 generic names
    of 20 enterprises.
    All public medical institutions in the province have been implemented
    since December 20.
    The price adjustment range of the drug is 0.
    01 yuan - 3162 yuan, involving ibuprofen suspension, Bairui granules and other products, the specific adjustments are as follows:
     
    On May 27, the Wuhan Municipal Medical Insurance Bureau issued a notice to dynamically adjust the information of some drugs listed on the Internet, involving newly listed drugs, patented drugs, drugs prone to shortage, evaluated generic drugs, ordinary generic drugs, etc
    .
    The notice shows that 18 generic names of 12 enterprises and 25 drugs listed on the Internet have been reduced, with a reduction range of 0.
    01 yuan to 566.
    3 yuan
    .

     
    It is understood that on May 14, in fact, Wuhan has adjusted the prices of 32 drugs under 31 generic names of 23 enterprises and the specifications of 2 drugs as required, and the prices of 32 drugs have been reduced by
    0.
    01-650 yuan.

     
    On March 1, Jiangsu Province Drug Sunshine Procurement Network issued a notice
    on adjusting the supply price of some drugs.
    There are a total of 61 price-adjusted products, including: Simcere Pharmaceutical's lenvatinib mesylate capsules, Runamfit's milrinone injection, StonePharmaceutical's Ouyi's rivaroxaban tablets, Innovent Biologics' bevacizumab injection, Yangtze River Pharmaceutical's balanced salt rinse solution and other commonly used clinical drugs
    .

     
    Among them, Huaxia Shengsheng's levofloxacin lactate sodium chloride injection (100ml: 0.
    3g: 0.
    9g) was reduced from the original price of 39 yuan to 17 yuan, a price reduction of more than 56%; The dual grade of emmetrituzumab for injection (100mg, 160mg) produced by Roche Pharmaceutical also decreased by 52.
    29%.

     
    In addition, as early as January, the Pharmaceutical Price and Bidding and Procurement Department of Hunan Provincial Medical Insurance Bureau also issued the Notice on Price Correction and Price Limit Listing of Some Drugs, which included 9 injections and one sustained-release agent, namely Citicoline, betalastine, Piracetam, Chuanxiongzine, famotidine, ranitidine, troxrutin, aminophylline, diprophylline, and theophylline
    .
    Among them, ranitidine, as well as troxerutin, betalastine, etc.
    are commonly used varieties
    .

     
    Analysts believe that at present, there are continuous drug price reductions, mainly due to the normalization and intensive promotion of centralized procurement of drugs from the state to the local government, and are constantly refreshing the minimum online prices of provincial platform products to urge enterprises to take the initiative to adjust prices and squeeze the space
    for inflated pharmaceutical prices.

     
    Under the background that the National Health Insurance Administration has clarified that during the "14th Five-Year Plan" period, it will increase the centralized procurement of drugs and medical consumables, promote centralized procurement with volume as the dominant model, normalize and institutionalize the national centralized procurement of drugs, and continue to expand the scope of centralized procurement of high-value medical consumables, the industry expects that more and more drugs and consumables will join the army of price reductions and benefit more patients
    in the future.

     
    ={"common":{"bdSnsKey":{},"bdText":"","bdMini":"1","bdMiniList":false,"bdPic":"","bdStyle":"0","bdSize":"32"},"share":{},"image":{"viewList":[" weixin","sqq","qzone","tsina","tqq","tsohu","tieba","renren","youdao","fx","ty","fbook","twi","copy","print"],"viewText":"share:","viewSize":"24"},"selectShare":{" bdContainerClass":null,"bdSelectMiniList":["weixin","sqq","qzone","tsina","tqq","tsohu","tieba","renren","youdao","fx","ty","fbook","twi","copy","print"]}}; with(document)0[(getElementsByTagName('head')[0]|| body).
    appendChild(createElement('script')).
    src='http://bdimg.
    share.
    baidu.
    com/static/api/js/share.
    js?v=89860593.
    js?cdnversion='+~(-new Date()/36e5)];
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.